Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV, Combination Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00002124
What this trial is testing

A Double-Blind, Randomized, Dose Response Study of Three Doses of Delavirdine Mesylate (U-90152S) in Combination With Zidovudine (ZDV) Versus ZDV Alone in HIV-1 Infected Individuals With CD4 Counts of 200-500mm3

Who this might be right for
HIV Infections
Pharmacia and Upjohn 1,250
Large-scale testing (Phase 3)Study completedNCT00001047
What this trial is testing

Study of Four Different Treatment Approaches for Patients Who Have Mycobacterium Avium Complex Disease (MAC) Plus AIDS

Who this might be right for
Mycobacterium Avium-intracellulare InfectionHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 400
Early research (Phase 1)Ended earlyNCT03571204
What this trial is testing

Combination Therapy With 3BNC117 and 10-1074 in HIV-Infected Individuals

Who this might be right for
HIV
National Institute of Allergy and Infectious Diseases (NIAID) 27
Testing effectiveness (Phase 2)Study completedNCT04042740
What this trial is testing

Glecaprevir/Pibrentasvir Fixed-dose Combination Treatment for Acute Hepatitis C Virus Infection

Who this might be right for
Hepatitis C InfectionHIV Infection
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 45
Large-scale testing (Phase 3)UnknownNCT00006208
What this trial is testing

A Comparison of Emtricitabine and Stavudine Used With Didanosine Plus Efavirenz in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs

Who this might be right for
HIV Infections
Triangle Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT00000940
What this trial is testing

Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 121
Large-scale testing (Phase 3)Study completedNCT00002199
What this trial is testing

A Phase III Randomized Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of 3TC/ZDV/1592U89 and 3TC/ZDV/IDV in HIV-1 Infected Antiretroviral Therapy-Naive Subjects.

Who this might be right for
HIV Infections
Glaxo Wellcome 550
Testing effectiveness (Phase 2)Study completedNCT00001063
What this trial is testing

The Effectiveness of Three Drug Combinations in HIV-Infected Patients Who Have Taken Zidovudine for More Than 12 Weeks

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 200
Large-scale testing (Phase 3)Study completedNCT03178084
What this trial is testing

Effects of Maraviroc vs. Efavirenz on CD4/CD8 Ratio

Who this might be right for
HIV/AIDS
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 721
Testing effectiveness (Phase 2)Study completedNCT00006152
What this trial is testing

See If Taking One or Two Extra Drugs Can Lower HIV Levels in Patients Who Have Failed Their Anti-HIV Drug Treatment

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 42
Large-scale testing (Phase 3)Study completedNCT00002193
What this trial is testing

Safety and Effectiveness of Giving Two Nucleoside Reverse Transcriptase Inhibitors Alone or in Combination With 141W94 to HIV-Infected Children Who Have Never Received Protease Inhibitors

Who this might be right for
HIV Infections
Glaxo Wellcome 210
Large-scale testing (Phase 3)Study completedNCT02733419
What this trial is testing

Efficacy, and Safety Study of Optimized Background Antiretroviral Regimen (OB) in Combination With Enfuvirtide in the Treatment-Experienced Participants With Human Immunodeficiency Virus-1 (HIV-1) Infection

Who this might be right for
HIV Infections
Hoffmann-La Roche 84
Not applicableStudy completedNCT00112593
What this trial is testing

Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Undifferentiated LeukemiaAdult Acute Lymphoblastic Leukemia in Remission+176 more
Fred Hutchinson Cancer Center 5
Early research (Phase 1)Study completedNCT02028403
What this trial is testing

Safety and Immune Response of BMS-936559 in HIV-Infected People Taking Combination Antiretroviral Therapy

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 8
Testing effectiveness (Phase 2)Ended earlyNCT00768989
What this trial is testing

Phase IIB Pilot of Atazanavir + Raltegravir

Who this might be right for
HIV
Bristol-Myers Squibb 167
Testing effectiveness (Phase 2)Ended earlyNCT01737359
What this trial is testing

A Safety and Efficacy Study of Amdoxovir in HIV-1 Treatment-experienced Subjects.

Who this might be right for
Human Immunodeficiency Virus Infection
RFS Pharma, LLC 2
Not applicableStudy completedNCT00002217
What this trial is testing

Combivir Plus Abacavir Plus 141W94 in Patients Who Previously Have Used Anti-HIV Drugs

Who this might be right for
HIV Infections
Glaxo Wellcome
Testing effectiveness (Phase 2)Study completedNCT00445146
What this trial is testing

Safety of EVG+RTV Administered With Other Antiretroviral Agents for the Treatment of HIV-1 Infection

Who this might be right for
HIV Infections
Gilead Sciences 192
Post-approval studies (Phase 4)Study completedNCT00335322
What this trial is testing

ALTAIR - Alternative Antiretroviral Strategies : a Comparison of Three Initial Regimens

Who this might be right for
Human Immunodeficiency Virus (HIV)
Kirby Institute 329
Large-scale testing (Phase 3)Study completedNCT00002105
What this trial is testing

Randomized, Comparative Trial of DOX-SL (Stealth Liposomal Doxorubicin Hydrochloride) Versus Bleomycin and Vincristine in the Treatment of AIDS-Related Kaposi's Sarcoma

Who this might be right for
Sarcoma, KaposiHIV Infections
Sequus Pharmaceuticals 220
Next Page